| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |